-
1.
公开(公告)号:WO2017127306A1
公开(公告)日:2017-07-27
申请号:PCT/US2017/013560
申请日:2017-01-13
申请人: ARISAN THERAPEUTICS
发明人: PLEWE, Michael , BROWN, Eric , GANTLA, Vidyasagar , HENKEL, Gregory , MCCORMACK, Kenneth , SOKOLOVA, Nadezda
IPC分类号: A61K31/015 , A61K31/135 , A61K31/165 , C07C13/28 , C07C13/54 , C07C13/573
CPC分类号: A61K31/015 , A61K31/135 , A61K31/165 , C07C217/58 , C07C233/41 , C07C233/43 , C07C233/62 , C07C235/40 , C07C237/24 , C07C275/26 , C07C2601/14 , C07C2603/74 , C07D205/04 , C07D205/12 , C07D209/94 , C07D211/34 , C07D211/56 , C07D211/58 , C07D211/60 , C07D211/62 , C07D213/74 , C07D213/75 , C07D213/82 , C07D233/64 , C07D243/08 , C07D295/03 , C07D295/088 , C07D295/13 , C07D295/185 , C07D295/192 , C07D295/26 , C07D295/32 , C07D451/04 , C07D453/02 , C07D487/04 , C07D487/06 , C07D487/10
摘要: Compounds of structural Formula (I) were developed for the treatment of infections by filoviruses including Ebolavirus and Marburgvirus.
摘要翻译: 开发了结构式(I)的化合物用于治疗包括埃博拉病毒和马尔堡病毒在内的病毒的感染。 p>
-
公开(公告)号:WO2018013430A3
公开(公告)日:2018-01-18
申请号:PCT/US2017/041218
申请日:2017-07-07
发明人: PLEWE, Michael , BROWN, Eric , GANTLA, Vidyasagar , HENKEL, Gregory , MCCORMACK, Kenneth , SOKOLOVA, Nadzeda V. , SHIN, Young-Jun
IPC分类号: A61K31/41 , A61K31/407 , A61K31/4164 , C07D401/02 , C07D403/00 , C07D403/02
摘要: The invention relates to compounds of structural formula I, wherein A, D, and E are independently N or C-R 3 , G, H, and J are independently N or C, K is N or C-H, L is N, N-R 3 or C-R 3 , and A, D, E, G, H, J, K, and L together cannot have more than 4 N, R 1 is selected from (C 6 to C 10 ) aryl, (C 2 to C 9 ) heteroaryl, and 5-indolyl, wherein each of the said (C 6 to C 10 ) aryl and (C 2 to C 9 ) heteroaryl is substituted with at least one R 4a group, and wherein said (C 2 to C 9 ) heteroaryl is C-attached, and R 2 is selected from the group consisting of (i), (ii), (iii), and (iv).
-
公开(公告)号:WO2018013430A2
公开(公告)日:2018-01-18
申请号:PCT/US2017/041218
申请日:2017-07-07
发明人: PLEWE, Michael , BROWN, Eric , GANTLA, Vidyasagar , HENKEL, Gregory , MCCORMACK, Kenneth , SOKOLOVA, Nadzeda V. , SHIN, Young-Jun
IPC分类号: A61K31/4745 , A61K31/4184
摘要: The invention relates to compounds of structural formula I, wherein A, D, and E are independently N or C-R 3 , G, H, and J are independently N or C, K is N or C-H, L is N, N-R 3 or C-R 3 , and A, D, E, G, H, J, K, and L together cannot have more than 4 N, R 1 is selected from (C 6 to C 10 ) aryl, (C 2 to C 9 ) heteroaryl, and 5-indolyl, wherein each of the said (C 6 to C 10 ) aryl and (C 2 to C 9 ) heteroaryl is substituted with at least one R 4a group, and wherein said (C 2 to C 9 ) heteroaryl is C-attached, and R 2 is selected from the group consisting of (i), (ii), (iii), and (iv).
摘要翻译: 本发明涉及结构式I的化合物,其中A,D和E独立地为N或CR 3,G,H和J独立地为N或C ,K是N或CH,L是N,NR 3或CR 3,并且A,D,E,G,H,J,K和L一起不能 具有多于4个N,R 1选自(C 6至C 10)芳基,(C 2 sub> 其中每个所述(C 6至C 10)芳基和(C 6至C 10)芳基各自独立地选自氢, 2至C 9)杂芳基被至少一个R 4a基团取代,并且其中所述(C 2至C 4) (i),(ii),(iii)和(iv)组成的组中,R 2是C连接的,且R 2选自(i),(ii),(iii)和(iv)。 p>
-
公开(公告)号:WO2017127306A4
公开(公告)日:2017-07-27
申请号:PCT/US2017/013560
申请日:2017-01-13
申请人: ARISAN THERAPEUTICS
发明人: PLEWE, Michael , BROWN, Eric , GANTLA, Vidyasagar , HENKEL, Gregory , MCCORMACK, Kenneth , SOKOLOVA, Nadezda
IPC分类号: A61K31/015 , A61K31/135 , A61K31/165 , C07C13/28 , C07C13/54 , C07C13/573
摘要: Compounds of structural Formula (I) were developed for the treatment of infections by filoviruses including Ebolavirus and Marburgvirus.
-
-
-